However, attempts to use IGF-1 to prevent cachexia have been limited due to the toxicity related both in terms of the action of IGF-1 increasing glucose blood levels and the relevant anabolic sequelae, including the major propensity to tumor growth of an IGF-1-enriched microenvironment [145]. Here, IGF1 is linked to neoplasm.